Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celgene, others regenerate biotech Tengion's finances with $33.6M
Fierce Biotech
Tuesday, July 2, 2013 - 9:42am
tags:
Celgene, Tengion
Roche's (RHHBY) Genentech Receives FDA Priority Review for Perjeta
Street Insider
Tuesday, July 2, 2013 - 9:38am
tags:
Roche, Genentech, FDA, Perjeta, breast cancer
Roche Buys Constitution Medical for $220 Million
Bloomberg
Tuesday, July 2, 2013 - 9:34am
tags:
Constitution Medical, M&A, Roche
NanoString says study demonstrates advantages of breast cancer assay
Yahoo/Fly on the Wall
Tuesday, July 2, 2013 - 9:33am
tags:
NanoString, breast cancer, Prosigna Breast Cancer Prognostic Gene Signature Assay
Arena Fans Spinning (And Altering) Belviq Prescription Data
TheStreet.com
Tuesday, July 2, 2013 - 9:31am
tags:
Arena Pharmaceuticals, Belviq, obesity
Vivus's Qsymia Now Available At 8,000 Pharmacies - Is It Enough?
Seeking Alpha
Tuesday, July 2, 2013 - 9:30am
tags:
Vivus, Qsymia, obesity
Korean Partner Positions Pluristem To Be Cell Therapy Leader
Seeking Alpha
Tuesday, July 2, 2013 - 1:40am
tags:
Korea, Pluristem, Advanced Cell Technology, Cha Bio&Diostech
An Interesting Bio Play in the Blood Disorder Niche
Motley Fool
Tuesday, July 2, 2013 - 1:39am
tags:
hereditary angiodema, Dyax, Shire, CSL, ViroPharma, Biovitrum, Halozyme, Cinryze
ImmunoCellullar Therapeutics' Immune Modifying Approach To Cancer Is Worth Watching
Seeking Alpha
Tuesday, July 2, 2013 - 1:36am
tags:
ImmunoCellular Therapeutics, cancer, Dendreon, ICT-107
1 Reason to Expect Big Things from Allergan
Motley Fool
Tuesday, July 2, 2013 - 1:33am
tags:
Allergan
Pfizer, Novartis may join Amgen in bidding for Onyx: sources
Yahoo/Reuters
Tuesday, July 2, 2013 - 1:32am
tags:
Pfizer, Novartis, Amgen, ONYX Pharmaceutical, M&A
Achillion Hepatitis C Drug Trial on Hold on Liver Concern
Bloomberg
Tuesday, July 2, 2013 - 1:25am
tags:
Achillion, hepatitis C, sovaprevir
Teva trial data back higher dosage Copaxone
Globes, Israel
Monday, July 1, 2013 - 1:56pm
tags:
Teva, Copaxone, MS, multiple sclerosis
King Pharmaceuticals to pay $2.2M civil penalty for plant violations
Med City News
Monday, July 1, 2013 - 1:54pm
tags:
Pfizer, King Pharmaceuticals, drug manufacturing, Clean Air Act
Why Ligand Pharmaceuticals Shares Popped
Motley Fool
Monday, July 1, 2013 - 1:52pm
tags:
Ligand, hot flashes, Brisdelle, Hisamitsu, Pfizer, bazedoxifene
Biotech IPOs boom in Q2, enjoying a long-awaited embrace from investors
Fierce Biotech
Monday, July 1, 2013 - 1:10pm
tags:
biotech, IPOs
Vivus announces initial availability of Qsymia through certified pharmacies
Yahoo/Fly on the Wall
Monday, July 1, 2013 - 1:07pm
tags:
Qsymia, obesity, Vivus
Breaking Down Dendreon's European Recommendation
Motley Fool
Monday, July 1, 2013 - 1:06pm
tags:
Provenge, Europe, Dendreon, prostate cancer
Arena's Second Week Sales - Not Bad, But Not Good Either
Seeking Alpha
Monday, July 1, 2013 - 12:55pm
tags:
Arena Pharmaceuticals, Eisai, obesity, Belviq
The Best- And Worst-Performing Biotech Stocks In The First Half Of 2013
Forbes
Monday, July 1, 2013 - 12:54pm
tags:
biotech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.